HIV/AIDS Policy: HIV/AIDS Drug Patents
- Financial Times Examines Intellectual Property Debate in India (May 16, 2013)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- GlaxoSmithKline's HIV/AIDS Business Joins Medicines Patent Pool (February 28, 2013)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Florida A&M University Professor Receives Patent for Highly Effective Anti-HIV Compounds (December 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Indonesia in Bold Move to Obtain Cheap Drugs for HIV (October 16, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Private Negotiations Over Trans-Pacific Partnership Agreement Conclude (October 15, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Médecins Sans Frontières Launches Online "Patent Opposition Database" (October 9, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Gilead Sciences Signs Deals With Three Indian Pharmaceutical Companies to Promote Low-Cost HIV Drugs in Developing Countries (August 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- First Generic HIV Drugs Could Save U.S. at Least $920 Million a Year (July 27, 2012)
From aidsmap.com
- For Big Drug Companies, a Headache Looms (July 27, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- Intellectual Property "Still a Threat," to Antiretroviral Access, Says Panel (July 26, 2012)
From aidsmap.com
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
